FDA OKs First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
The U.S. FDA has approved Gallium 68 PSMA-11 (Ga 68 PSMA-11)—the first drug for PET imaging of prostate-specific membrane antigen positive lesions in men with prostate cancer.
Category: Nuclear Medicine
Nuclear Medicine
Latest
Nuclear Medicine
Latest
PET/MRI Improves Lesion Detection, Reduces Radiation Exposure
A single-center observational study of more than 1,000 oncological examinations has demonstrated that PET/ MRI facilitates cancer staging as well as PET/CT and improves lesion detectability in select cancers, potentially helping to promote fast, efficient local and whole-body staging in one step.
Nuclear Medicine
Popular
PET/CT Monitors Therapy Effectiveness for Melanoma Patients
Metastatic melanoma is one of the deadliest skin cancers, so determination of a treatment’s effectiveness is essential but can be tricky. Fortunately, a new study demonstrates that 18F-FDG PET/CT can monitor immunotherapy with ipilimumab, a “checkpoint inhibitor” that allows the immune system to attack cancer cells.
Novel Radiotracer Aids Imaging in Patients with Liver-Dominant Disease
In a head-to-head comparison, 68Ga-DOTA-JR11 PET/CT performed better than 68Ga-DOTATATE PET/CT in detecting liver metastases.
Read More
PyL PET Tracer May Be Superior to Standard Imaging for Prostate Cancer
PSMA-targeted 18F-DCFPyL-PET/CT imaging demonstrated excellent diagnostic performance in men with biochemically relapsed prostate cancer.
Read More
PET/CT Assesses Brain Stem Function in Hearing Impaired Patients
Novel, fully digital, high-resolution PET/CT imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment.
Read More
PET Offers New Insights into Post-Transplant Care for Heart Patients
Myocardial blood flow and myocardial flow reserve have been identified as accurate indicators for graft failure after cardiac transplantation, according to a new study published in The Journal of Nuclear Medicine.
Read More
Unconventional Radiopharmaceutical May Better Detect Neuroendocrine Tumors
The newly developed imaging agent has emerged as a more accurate and sensitive radiopharmaceutical to aid in the diagnosis of neuroendocrine tumor metastases.
Read More